Data / Form D filings / Context Therapeutics Inc.
Context Therapeutics Inc.: Form D filing
Context Therapeutics Inc., a pharmaceuticals company in Philadelphia, PA, filed a Form D with the SEC in 2024. The latest, on May 16, 2024, reports $100 million sold of a $100 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, Philadelphia, PA, 19103
- Phone
- (267) 225-7416
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1842952
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 16, 2024 | New notice | $99,998,250 | $99,992,767 | $5,483 | 26 | May 6, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alex Albert Levit | Executive Officer | |
| Linda Beth West | Director | |
| Martin Albert Lehr | Executive Officer, Director | |
| Richard Jay Berman | Director | |
| Philip Jay Kantoff | Director | |
| Jennifer Albert Minai-Azary | Executive Officer | |
| Jennifer Beth Evans Stacey | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of May 13, 2024 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Context Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.